Home » Monoamine Oxidase Inhibitors in Neurological Diseases by Abraham N. Lieberman
Monoamine Oxidase Inhibitors in Neurological Diseases Abraham N. Lieberman

Monoamine Oxidase Inhibitors in Neurological Diseases

Abraham N. Lieberman

Published January 1st 1994
ISBN : 9780824790820
Hardcover
400 pages
Enter the sum

 About the Book 

Emphasizing the role of monoamine oxidase (MAO) in the etiology and pathogenesis of Parkinsons disease and Alzheimers disease, this up-to-date reference describes the genetics, physiology, biochemistry, pharmacology, and clinical aspects of thisMoreEmphasizing the role of monoamine oxidase (MAO) in the etiology and pathogenesis of Parkinsons disease and Alzheimers disease, this up-to-date reference describes the genetics, physiology, biochemistry, pharmacology, and clinical aspects of this very important class of enzymes.Details how the interaction between selegiline (deprenyl) and MAO may retard the progression of neurodegenerative disorders!Providing the latest theories on how selegiline operates, Monoamine Oxidase Inhibitors in Neurological Diseasespresents fundamental information on MAO types A and Bexamines the distribution of MAO A and B in the normal human braininvestigates the effects of disease and aging on MAO A and Banalyzes a critical role for MAO in the toxic action in Parkinsons diseaseelucidates selegilines novel ability to delay the progression or repair the damage of dopaminergic neuronsdiscusses the usefulness of MAO inhibitors in psychiatric diseaseand more!